Overview Dividends

(DORM) Dorman Products - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2582781009

Engine, Suspension, Body, Electronics, Hardware

DORM EPS (Earnings per Share)

EPS Growth (3Y CAGR): 41.43%
EPS Trend (3Y Correlation): 88.5%

DORM Revenue

Revenue Growth (3Y CAGR): 3.00%
Revenue Trend (3Y Correlation): 78.3%

Risk via 10d forecast
Volatility	33.7%
Value at Risk 5%th	49.4%
Relative Tail Risk	-10.83%

Reward TTM
Sharpe Ratio	-0.10
Alpha	-15.56

Character TTM
Hurst Exponent	0.488
Beta	0.702
Beta Downside	0.682

Drawdowns 3y
Max DD	38.85%
Mean DD	12.37%
Median DD	11.68%

Description: DORM Dorman Products November 09, 2025

Dorman Products (NASDAQ:DORM) is a U.S.–based supplier of replacement and upgrade parts for the motor-vehicle aftermarket, serving light-duty, heavy-duty, and specialty-vehicle segments. Its catalog spans engine, under-car, steering-suspension, body, electronics, and hardware components, marketed under brands such as DORMAN, HELP! and SuperATV, and includes OE-FIX solutions that target both original-equipment manufacturers and independent repair shops.

Key data points (FY 2023): revenue of $2.1 billion, operating margin of ≈ 6.5 %, and a 4 % year-over-year growth in aftermarket sales driven by higher vehicle-age penetration and an expanding UTV market. The segment’s performance is closely linked to macro trends such as vehicle miles traveled (VMT) growth, which historically adds ~0.5 % to aftermarket demand per percentage-point VMT increase, and the ongoing shift toward electric-vehicle (EV) platforms, where Dorman is beginning to develop EV-specific thermal-management and electronic modules.

If you want a data-rich, unbiased view of Dorman’s valuation and risk profile, a quick look at ValueRay’s analyst dashboard can help you spot any gaps in the public narrative before you dive deeper.

DORM Stock Overview

Market Cap in USD	4,104m
Sub-Industry	Automotive Parts & Equipment
IPO / Inception	1991-03-12
Return 12m vs S&P 500	-15.5%
Analyst Rating	3.75 of 5

DORM Dividends

Currently no dividends paid

DORM Growth Ratios

CAGR 3y	13.75%
CAGR/Max DD Calmar Ratio	0.35
CAGR/Mean DD Pain Ratio	1.11
Current Volume	153.5k
Average Volume	241.1k

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (247.1m TTM) > 0 and > 6% of Revenue (6% = 127.6m TTM)

FCFTA 0.04 (>2.0%) and ΔFCFTA -3.14pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 37.91% (prev 38.32%; Δ -0.41pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.06 (>3.0%) and CFO 143.4m <= Net Income 247.1m (YES >=105%, WARN >=100%)

Net Debt (515.6m) to EBITDA (416.2m) ratio: 1.24 <= 3.0 (WARN <= 3.5)

Current Ratio 2.43 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (30.8m) change vs 12m ago 0.14% (target <= -2.0% for YES)

Gross Margin 41.88% (prev 39.54%; Δ 2.33pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 88.80% (prev 83.32%; Δ 5.48pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 11.67 (EBITDA TTM 416.2m / Interest Expense TTM 30.9m) >= 6 (WARN >= 3)

Altman Z'' 5.87

(A) 0.33 = (Total Current Assets 1.37b - Total Current Liabilities 563.8m) / Total Assets 2.42b

(B) 0.49 = Retained Earnings (Balance) 1.18b / Total Assets 2.42b

(D) 1.04 = Book Value of Equity 1.17b / Total Liabilities 1.13b

Total Rating: 5.87 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 78.49

1. Piotroski 6.0pt = 1.0

2. FCF Yield 2.28% = 1.14

3. FCF Margin 4.96% = 1.24

4. Debt/Equity 0.44 = 2.40

5. Debt/Ebitda 1.24 = 1.41

6. ROIC - WACC (= 7.56)% = 9.45

7. RoE 18.57% = 1.55

8. Rev. Trend 78.35% = 5.88

9. EPS Trend 88.52% = 4.43

What is the price of DORM shares?

As of November 16, 2025, the stock is trading at USD 131.75 with a total of 153,490 shares traded.
Over the past week, the price has changed by -1.89%, over one month by -5.93%, over three months by -15.45% and over the past year by -3.10%.

Is Dorman Products a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Dorman Products (NASDAQ:DORM) is currently (November 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 78.49 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DORM is around 113.53 USD . This means that DORM is currently overvalued and has a potential downside of -13.83%.

Is DORM a buy, sell or hold?

Dorman Products has received a consensus analysts rating of 3.75. Therefor, it is recommend to hold DORM.

Strong Buy: 0
Buy: 3
Hold: 1
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the DORM price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	173.5	31.7%
Analysts Target Price	173.5	31.7%
ValueRay Target Price	125.6	-4.6%

DORM Fundamental Data Overview November 10, 2025

Market Cap USD = 4.10b (4.10b USD * 1.0 USD.USD)
P/E Trailing = 16.7235
P/E Forward = 16.2338
P/S = 1.9304
P/B = 3.398
P/EG = 1.37
Beta = 0.881
Revenue TTM = 2.13b USD
EBIT TTM = 360.7m USD
EBITDA TTM = 416.2m USD
Long Term Debt = 439.5m USD (from longTermDebt, last fiscal year)
Short Term Debt = 28.1m USD (from shortTermDebt, last quarter)
Debt = 572.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 515.6m USD (from netDebt column, last quarter)
Enterprise Value = 4.62b USD (4.10b + Debt 572.8m - CCE 57.1m)
Interest Coverage Ratio = 11.67 (Ebit TTM 360.7m / Interest Expense TTM 30.9m)
FCF Yield = 2.28% (FCF TTM 105.4m / Enterprise Value 4.62b)
FCF Margin = 4.96% (FCF TTM 105.4m / Revenue TTM 2.13b)
Net Margin = 11.62% (Net Income TTM 247.1m / Revenue TTM 2.13b)
Gross Margin = 41.88% ((Revenue TTM 2.13b - Cost of Revenue TTM 1.24b) / Revenue TTM)
Gross Margin QoQ = 44.40% (prev 40.58%)
Tobins Q-Ratio = 1.91 (Enterprise Value 4.62b / Total Assets 2.42b)
Interest Expense / Debt = 1.26% (Interest Expense 7.21m / Debt 572.8m)
Taxrate = 23.52% (23.5m / 99.9m)
NOPAT = 275.8m (EBIT 360.7m * (1 - 23.52%))
Current Ratio = 2.43 (Total Current Assets 1.37b / Total Current Liabilities 563.8m)
Debt / Equity = 0.44 (Debt 572.8m / totalStockholderEquity, last quarter 1.29b)
Debt / EBITDA = 1.24 (Net Debt 515.6m / EBITDA 416.2m)
Debt / FCF = 4.89 (Net Debt 515.6m / FCF TTM 105.4m)
Total Stockholder Equity = 1.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.19% (Net Income 247.1m / Total Assets 2.42b)
RoE = 18.57% (Net Income TTM 247.1m / Total Stockholder Equity 1.33b)
RoCE = 20.37% (EBIT 360.7m / Capital Employed (Equity 1.33b + L.T.Debt 439.5m))
RoIC = 15.23% (NOPAT 275.8m / Invested Capital 1.81b)
WACC = 7.66% (E(4.10b)/V(4.68b) * Re(8.60%) + D(572.8m)/V(4.68b) * Rd(1.26%) * (1-Tc(0.24)))
Discount Rate = 8.60% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.16%
[DCF Debug] Terminal Value 77.36% ; FCFE base≈134.0m ; Y1≈143.9m ; Y5≈175.9m
Fair Price DCF = 90.57 (DCF Value 2.77b / Shares Outstanding 30.6m; 5y FCF grow 8.22% → 3.0% )
EPS Correlation: 88.52 | EPS CAGR: 41.43% | SUE: 0.58 | # QB: 0
Revenue Correlation: 78.35 | Revenue CAGR: 3.00% | SUE: -0.40 | # QB: 0

Additional Sources for DORM Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle